Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Fresenius Medical Care

Founders Eduard Fresenius

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 16
Average round size
info
The average size of a deal this fund participated in
$37M
Portfolio companies 11
Rounds per year 0.59
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.31
Exits 2
Key employees 24

Areas of investment

  • Medical
  • Health Care
  • Biotechnology
  • Medical Device
  • Information Technology
Summary

In 1996 was created Fresenius Medical Care, which is appeared as Corporate Investor. The venture was found in Europe in Germany. The main department of described Corporate Investor is located in the Homburg.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Fresenius Medical Care, startups are often financed by Zohar Gilon, California Institute for Regenerative Medicine, Amplify.LA. The meaningful sponsors for the fund in investment in the same round are Mitsubishi UFJ Capital, Grey Sky Venture Partners, ehuda Zisafe. In the next rounds fund is usually obtained by Pangaea Ventures, National Institutes of Health, Mitsubishi UFJ Capital.

The high activity for fund was in 2018. This Fresenius Medical Care works on 16 percentage points less the average amount of lead investments comparing to the other organizations. The fund is constantly included in less than 2 deals per year. The real fund results show that this Corporate Investor is 30 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 10 - 50 millions dollars. The average startup value when the investment from Fresenius Medical Care is 500 millions - 1 billion dollars.

This organization was formed by Eduard Fresenius. The overall number of key employees were 25.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Corvidia, Tridiuum, Vectorious Medical Technologies Among the most successful fund investment fields, there are Genetics, Therapeutics. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Fresenius Medical Care:
Typical Co-investors
Fresenius Medical Care is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Fresenius Medical Care:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BCI Europe -
Bedrock Capital New York, New York, United States
Berlin.de Berlin, Berlin, Germany
BIA Digital Partners Chantilly, United States, Virginia
Brentwood Capital Advisors Franklin, Tennessee, United States
Equity.com Missouri, St Louis, United States
Fengate Real Asset Investments Canada, Ontario, Toronto
Fremont Ventures California, San Francisco, United States
HB Reavis England, London, United Kingdom
Indo-US Venture Partners California, Santa Clara, United States
National Grid Partners (NGP) California, San Francisco, United States
Numenta California, Redwood City, United States
Perion Investment Fund Budapest, Hungary
Spruce Capital Partners California, San Francisco, United States
Sympasis Innovation Capital Baden-Wurttemberg, Ettlingen, Germany
Tango Ventures Maine, Northern Washington Co, United States
Technology 9 Labs (T9L) Delhi, India, New Delhi
Techstars Montreal AI Accelerator Canada, Montréal, Quebec
Whitewater CDA United States, Whitewater, Wisconsin

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Memo Therapeutics

Biotechnology
Collaboration
$27M02 Nov 2023 Zurich, Zurich, Switzerland

Memo Therapeutics

Biotechnology
Collaboration
$25M16 Feb 2022 Zurich, Zurich, Switzerland

SafeRide Health

Health Care
Transportation
08 Nov 2021 California, United States

EGenesis

Biopharma
Biotechnology
Genetics
Life Science
Medical
$100M07 Nov 2019 Cambridge, Massachusetts, United States

Health Care
$25M09 Jul 2019 Golden, Colorado, United States

SafeRide Health

Health Care
Transportation
20 Feb 2019 California, United States

Modulim

Market Research
Product Research
$7M23 Jan 2019 Irvine, California, United States

Tridiuum

Biotechnology
Health Care
Hospital
Information Technology
$9M18 Dec 2018 Philadelphia, Pennsylvania, United States

Vectorious Medical Technologies

Health Care
Information Technology
Medical
Medical Device
Wireless
$2M16 Jul 2018 Tel Aviv-Yafo, Tel Aviv District, Israel
News
eGenesis Raises $125M in Series C Financing

– eGenesis from Cambridge, Mass. develops human-compatible organs, tissues, and cells.
– The company raised $125m in Series C funding.
– Backers included Farallon Capital Management, Polaris Partners, HBM Healthcare Investments, Invus, Samsara BioCapital, LifeSci Venture Partners, Irving Investors, Catalio Capital Management, SymBiosis, Altium Capital, Monashee Investment Management, and Osage University Partners and existing investors Leaps by Bayer, Fresenius Medical Care Ventures, ARCH Venture Partners, Wellington Partners, Khosla Ventures, and Alta Partners.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Fresenius Medical Care?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 16
Average round size 37M
Rounds per year 0.59
Peak activity year 2018
Lead investments 3
Follow on index 0.31
Exits 2
Group Appearance index 0.75

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Memo Therapeutics

Biotechnology
Collaboration
$27M02 Nov 2023 Zurich, Zurich, Switzerland

Memo Therapeutics

Biotechnology
Collaboration
$25M16 Feb 2022 Zurich, Zurich, Switzerland

SafeRide Health

Health Care
Transportation
08 Nov 2021 California, United States

EGenesis

Biopharma
Biotechnology
Genetics
Life Science
Medical
$100M07 Nov 2019 Cambridge, Massachusetts, United States

Health Care
$25M09 Jul 2019 Golden, Colorado, United States

SafeRide Health

Health Care
Transportation
20 Feb 2019 California, United States

Modulim

Market Research
Product Research
$7M23 Jan 2019 Irvine, California, United States

Tridiuum

Biotechnology
Health Care
Hospital
Information Technology
$9M18 Dec 2018 Philadelphia, Pennsylvania, United States

Vectorious Medical Technologies

Health Care
Information Technology
Medical
Medical Device
Wireless
$2M16 Jul 2018 Tel Aviv-Yafo, Tel Aviv District, Israel
Crunchbase icon

Content report

The following text will be sent to our editors: